Get the Stockscreener App
0.00
100.00%
-0.55
Marinus Pharmaceuticals Inc Stock (MRNS) Forecast
The Marinus Pharmaceuticals Inc (MRNS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.6268, representing a + increase from the current price of $0.00. The highest analyst price target is $6.4606, and the lowest is $4.793.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MRNS Price Target
Average 3.5757
(+ Upside)
Is Marinus Pharmaceuticals Inc (MRNS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 8.78 | Buy |
| STOCH(9,6) | 76.29 | Neutral |
| STOCHRSI(14) | 71.96 | Neutral |
| MACD(12,26) | -0.0207 | Sell |
| ADX(14) | 43.13 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -864.74 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4918
Sell
|
0.4467
Sell
|
| MA20 |
0.5169
Sell
|
0.4794
Sell
|
| MA50 |
0.422
Sell
|
0.5138
Sell
|
| MA100 |
0.7405
Sell
|
0.7905
Sell
|
| MA200 |
1.057
Sell
|
2.1915
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MRNS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MRNS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 8.78 indicates that MRNS is oversold. This indicates that MRNS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 76.29 indicates that MRNS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.96 indicates that MRNS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 43.13 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -864.74 indicates that MRNS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MRNS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Marinus Pharmaceuticals Inc financial reports and earnings history, Marinus Pharmaceuticals Inc (MRNS) stock could reach $16.08 by 2030, $7.2465 by 2040 and $33.41 by 2050. See the projected annual prices until 2050 of the Marinus Pharmaceuticals Inc stock below:
- Marinus Pharmaceuticals Inc (MRNS) is expected to reach an average price of $0.7797 in 2035, with a high prediction of $1.2173 and a low estimate of $0.1035. This indicates an $ rise from the last recorded price of $0.00.
- Marinus Pharmaceuticals Inc (MRNS) stock is projected to chart a bullish course in 2040, with an average price target of $4.8384, representing an $ surge from its current level. The forecast ranges from a conservative $5.9484 to a sky-high $7.2465.
- Our analysts predict Marinus Pharmaceuticals Inc (MRNS) to jump by 2045, soaring from $19.01 to an average price of $18.76, potentially reaching $19.31. While $19.01 is the low estimate, the potential upside is significant.
- Marinus Pharmaceuticals Inc (MRNS) stock is expected to climb by 2050, reaching an average of $30.76, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.41 and $33.52, respectively, highlighting the market's uncertainty.
Marinus Pharmaceuticals Inc Stock (MRNS) Year by Year Forecast
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2025
Marinus Pharmaceuticals Inc Stock (MRNS) is expected to reach an average price of $4.0411 in 2025, with a high prediction of $7.8036 and a low estimate of $0.2786. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $6.6806 | $4.793 | $6.4606 | + |
| May, 2025 | $6.8081 | $7.3681 | $7.1143 | + |
| June, 2025 | $4.7156 | $6.0356 | $5.7419 | + |
| July, 2025 | $2.71 | $3.7294 | $2.5163 | + |
| August, 2025 | $4.0376 | $3.5169 | $2.6376 | + |
| September, 2025 | $6.0051 | $6.2644 | $5.6782 | + |
| October, 2025 | $5.5195 | $5.3726 | $5.492 | + |
| November, 2025 | $0.193 | $1.727 | $4.4264 | + |
| December, 2025 | $0.6386 | $0.2786 | $3.5392 | + |
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2026
The predicted value for Marinus Pharmaceuticals Inc (MRNS) in 2026 is set at an average of $4.689. Estimates vary from a peak of $9.3408 to a trough of $0.0371, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.451 | $0.4017 | $4.111 | + |
| February, 2026 | $1.0035 | $0.6304 | $5.0573 | + |
| March, 2026 | $0.836 | $0.0371 | $2.036 | + |
| April, 2026 | $3.3016 | $0.3655 | $4.0016 | + |
| May, 2026 | $5.2241 | $2.1768 | $8.7009 | + |
| June, 2026 | $4.4465 | $2.5372 | $5.5472 | + |
| July, 2026 | $5.3721 | $2.429 | $5.6921 | + |
| August, 2026 | $8.0946 | $3.1702 | $8.1146 | + |
| September, 2026 | $8.6402 | $6.6177 | $9.3408 | + |
| October, 2026 | $2.7527 | $2.4227 | $9.0033 | + |
| November, 2026 | $2.4551 | $0.70 | $3.5158 | + |
| December, 2026 | $1.7207 | $1.3145 | $2.9383 | + |
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Marinus Pharmaceuticals Inc (MRNS) is $2.2294, with a high forecast of $4.3606 and a low forecast of $0.0981. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.7232 | $1.417 | $2.6501 | + |
| February, 2027 | $2.8457 | $1.6963 | $3.8426 | + |
| March, 2027 | $1.4813 | $0.0981 | $3.1188 | + |
| April, 2027 | $2.3337 | $1.0044 | $4.3606 | + |
| May, 2027 | $1.8762 | $0.60 | $2.5369 | + |
| June, 2027 | $0.9082 | $0.3144 | $3.7125 | + |
| July, 2027 | $1.3043 | $0.3013 | $4.218 | + |
| August, 2027 | $0.3232 | $0.1164 | $2.3505 | + |
| September, 2027 | $2.4677 | $1.3101 | $1.9677 | + |
| October, 2027 | $2.9952 | $2.7445 | $2.7252 | + |
| November, 2027 | $1.6927 | $2.4458 | $2.1658 | + |
| December, 2027 | $1.0771 | $1.5171 | $1.3096 | + |
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2028
In 2028, Marinus Pharmaceuticals Inc (MRNS) is projected to reach an average price of $3.5161, with a high projection of $7.015 and a low estimate of $0.0171. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1046 | $0.2346 | $0.8891 | + |
| February, 2028 | $0.1978 | $0.1322 | $0.7047 | + |
| March, 2028 | $0.4366 | $0.1909 | $0.6708 | + |
| April, 2028 | $1.4041 | $0.6535 | $1.2841 | + |
| May, 2028 | $2.2085 | $1.3479 | $1.5485 | + |
| June, 2028 | $0.154 | $0.926 | $1.6454 | + |
| July, 2028 | $1.5764 | $0.0171 | $2.2164 | + |
| August, 2028 | $1.342 | $1.092 | $2.532 | + |
| September, 2028 | $1.7845 | $0.9383 | $2.3645 | + |
| October, 2028 | $4.337 | $1.8076 | $4.747 | + |
| November, 2028 | $3.0626 | $2.3463 | $5.2801 | + |
| December, 2028 | $6.745 | $2.9304 | $7.015 | + |
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2029
The 2029 price forecast for Marinus Pharmaceuticals Inc Stock (MRNS) is $7.2726 on average, with a high prediction of $14.54 and a low estimate of $0.00593. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.7906 | $5.4675 | $6.9982 | + |
| February, 2029 | $3.4131 | $2.37 | $7.2137 | + |
| March, 2029 | $2.6756 | $2.6156 | $4.0525 | + |
| April, 2029 | $3.668 | $2.4187 | $4.9618 | + |
| May, 2029 | $3.0136 | $2.624 | $4.2412 | + |
| June, 2029 | $4.5811 | $2.9968 | $4.5961 | + |
| July, 2029 | $8.3486 | $4.6592 | $8.7286 | + |
| August, 2029 | $7.4842 | $6.8179 | $8.8448 | + |
| September, 2029 | $7.7266 | $7.0072 | $8.1385 | + |
| October, 2029 | $7.0322 | $6.266 | $8.5629 | + |
| November, 2029 | $0.1853 | $0.4553 | $7.6854 | + |
| December, 2029 | $15.50 | $0.00593 | $14.54 | + |
Marinus Pharmaceuticals Inc Stock (MRNS) Price Forecast for 2030
Marinus Pharmaceuticals Inc Stock (MRNS) is expected to reach an average price of $21.77 in 2030, with a high forecast of $28.00 and a low forecast of $15.54. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.27 | $16.13 | $16.08 | + |
| February, 2030 | $14.50 | $15.54 | $16.52 | + |
| March, 2030 | $28.12 | $17.44 | $28.00 | + |
| April, 2030 | $27.57 | $27.85 | $27.48 | + |
| May, 2030 | $25.46 | $25.48 | $25.28 | + |
| June, 2030 | $26.18 | $26.03 | $25.70 | + |
| July, 2030 | $26.43 | $26.24 | $26.13 | + |
| August, 2030 | $21.20 | $24.38 | $25.30 | + |
| September, 2030 | $21.34 | $21.65 | $20.90 | + |
| October, 2030 | $20.03 | $20.74 | $20.90 | + |
| November, 2030 | $23.00 | $19.27 | $19.54 | + |
| December, 2030 | $22.43 | $21.69 | $20.72 | + |
0.22%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):